P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY

被引:0
|
作者
Silvain, Johanne [1 ]
Storey, Robert [1 ]
Cayla, Guillaume [1 ]
Esteve, Jean-Baptiste [1 ]
Dillinger, Jean-Guillaume [1 ]
Vicat, Eric [1 ]
Collet, Jean-Philippe [1 ]
Tsatsaris, Anne [1 ]
Baradat, Caroline [1 ]
Salhi, Nejoua [1 ]
Lapostolle, Frederic [1 ]
Lassen, Jens [1 ]
Hamm, Christian [1 ]
Van't Hof, Arnoud [1 ]
Montalescot, Gilles [1 ]
机构
[1] ACT Coeur Res Grp, Paris, France
关键词
D O I
10.1016/S0735-1097(15)60221-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1244-057
引用
收藏
页码:A221 / A221
页数:1
相关论文
共 50 条
  • [11] Potent P2Y12 Receptor Inhibition in Korean Patients with Acute Myocardial Infarction
    Kim, Yongcheol
    Johnson, Thomas W.
    Jeong, Myung Ho
    KOREAN CIRCULATION JOURNAL, 2019, 49 (12) : 1199 - 1200
  • [12] Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction Insights From the Bern-PCI Registry
    Rohla, Miklos
    Ye, Shirley Xinyu
    Shibutani, Hiroki
    Bruno, Jolie
    Otsuka, Tatsuhiko
    Haner, Jonas D.
    Baer, Sarah
    Temperli, Fabrice
    Kavaliauskaite, Raminta
    Lanz, Jonas
    Stortecky, Stefan
    Praz, Fabien
    Hunziker, Lukas
    Pilgrim, Thomas
    Siontis, George CM.
    Losdat, Sylvain
    Windecker, Stephan
    Raeber, Lorenz
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (01) : 17 - 28
  • [13] Utilization of P2Y12 Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and Frailty
    Ko, Darae
    Pande, Ashvin
    Lin, Kueiyu Joshua
    Cervone, Alexander
    Bessette, Lily G.
    Lee, Su Been
    Cheng, Susan
    Glynn, Robert J.
    Kim, Dae Hyun
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 207 : 245 - 252
  • [14] Bending the Reluctance of No Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction
    Koliastasis, Leonidas
    Doundoulakis, Ioannis
    Xaplanteris, Panagiotis
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (06)
  • [15] Morphine Use in ST-Elevation Myocardial Infarction With Downstream P2Y12 Receptor Blockers-Insight From Observational Study
    Roguin, Ariel
    Kobo, Ofer
    Meisel, Simcha Ron
    Maraga, Emad
    Frimerman, Aaron
    Amsalem, Naama
    Malka, Rinat
    Levi, Yaniv
    Abu Fanne, Rami
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [16] Comparison of Heart Rates in Patients Initiated on Ticagrelor Versus Other P2Y12 Inhibitors After an Inferior ST Elevation Myocardial Infarction (STEMI)
    Law, Taylor M.
    Wohlfarth, Kevin M.
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (02) : 142 - 147
  • [17] Comparison of Heart Rates in Patients Initiated on Ticagrelor Versus Other P2Y12 Inhibitors After an Inferior ST Elevation Myocardial Infarction (STEMI)
    Law, Taylor M.
    Wohlfarth, Kevin M.
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (02) : 142 - 147
  • [18] Ticagrelor-Mono- or NOAK/P2Y12 according to DES-PCI: Less is more
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2020, 9 (01) : 14 - +
  • [19] Is Treatment of ST-Segment-Elevation Myocardial Infarction Patients With Ticagrelor or Other P2Y12 Inhibitors Before Primary Percutaneous Coronary Intervention a Strategy Without Benefit?
    Huber, Kurt
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (03)
  • [20] Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: Should we keep doing it?
    Proenca, Goncalo
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (10) : 563 - 564